Access our full analysis report here, it’s free. What The Market Is Telling Us Exact Sciences’s shares are very volatile and have had 23 moves greater than 5% over the last year.

Trump asserted on his Truth Social platform that Iran's nuclear sites sustained "monumental damage" in the American attack.

Tesla stock has soared this week on easing ... He received his M.A. in journalism from The New School and his B.A. in history and political science from McGill ... Jay L Clendenin / Getty Images.

This once-promising biotech is now struggling to stay afloat. Editor's Note: This article was updated on Aug. 31 to reflect that Labaton Sucharow was representing investors with a short position ...

The stock price of Cassava Sciences, ... See our analysis on Cassava Sciences Stock Chances of Rise for more details. Five Days: SAVA 1.3%, vs. S&P500 1.6%; Underperformed market ...

Fish stocks, rebounding from the exclusion of foreign fleets, began to crash again. NOAA regulators addressed overfishing ...

Exact Sciences cuts its 2024 revenue guidance from $2.81 billion-$2.85 billion to $2.73 billion-$2.75 billion. William Blair notes that management attributed the lower-than-expected guidance ...

Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined. The biopharma's profit got a lift from higher prices and demand for its HIV treatments.